You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
據報治療新冠藥物Paxlovid將於本月抵港
阿思達克 03-08 10:06
《星島日報》報道,本港現時有兩款藥物用於治療新冠病毒,包括默沙東藥廠(MRK.US)的Molnupiravir及美國輝瑞(PFE.US)的Paxlovid,前者已在公立醫院中使用,消息指後者將於3月中至3月尾抵港,屆時本港可有兩種藥物治療新冠病毒,惟由於該藥價值不菲,而且現時只允許公院使用,因此坊間不會購得有關藥物。 醫管局發言人表示,醫管局已根據專家意見採購合適數量治療新冠病毒的口服藥,部分藥物已開始使用,另有部分可望於短期內到港。醫生會根據專業診斷及病人的臨牀情況處方合適藥物。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account